Tag Archives: CREE

Canaccord Genuity Thinks Cree’s Stock is Going to Recover

In a report released yesterday, Jonathan Dorsheimer from Canaccord Genuity maintained a Buy rating on Cree (CREE – Research Report), with a price target of $44.00. The company’s shares closed last Thursday at $34.01, close to its 52-week low of

Cree (CREE) Gets a Hold Rating from Oppenheimer

In a report released today, Colin Rusch from Oppenheimer maintained a Hold rating on Cree (CREE – Research Report). The company’s shares closed last Thursday at $34.01, close to its 52-week low of $27.78. According to TipRanks.com, Rusch is a

Cree (CREE) Receives a Hold from Deutsche Bank

Deutsche Bank analyst Sidney Ho maintained a Hold rating on Cree (CREE – Research Report) today and set a price target of $42.00. The company’s shares closed last Monday at $38.77. According to TipRanks.com, Ho is a 5-star analyst with

Tuesday’s Midday Movers: uniQure NV (QURE), Cree (CREE), Royal Gold (RGLD), United States Steel (X), Intercept Pharma (ICPT)

So far Tuesday, October 15, NASDAQ is up 2.56% and the S&P is up 2.17%. Here are this morning’s most active stocks: uniQure NV (QURE – Research Report), Cree (CREE – Research Report), Royal Gold (RGLD – Research Report), United

Wednesday’s Midday Stock Update: Samsung Electronics (SSNLF), Cree (CREE), Akorn (AKRX), TrovaGene (TROV), Can-Fite BioPharma (CANF)

So far Wednesday, August 21, NASDAQ is up 0.22% and the S&P is up 0.1%. Here are this morning’s most active stocks: Samsung Electronics (SSNLF – Research Report), Cree (CREE – Research Report), Akorn (AKRX – Research Report), TrovaGene (TROV

Thursday’s Midday Stock Update: Weatherford (WFT), Cree (CREE), Rockwell Med (RMTI), Anthera Pharmaceuticals (ANTH), On Deck Capital Inc (ONDK)

So far Thursday, May 2, NASDAQ is down -1.4% and the S&P is down -0.72%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Weatherford (WFT – Research Report), Cree (CREE – Research Report),